Frank Sands's DXCM Position Overview
Frank Sands (via Sands Capital Management, LLC) currently holds 0 shares of DexCom, Inc. (DXCM) worth $0, representing 0.00% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 24 quarters.
Based on 13F filings, Frank Sands has maintained a strategic position in DXCM, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2020, adding 5.37 M shares. Largest reduction occurred in Q3 2025, reducing 5.01 M shares.
Analysis based on 13F filings available since 2013 Q2
Frank Sands's DexCom (DXCM) Holding Value Over Time
Track share changes against reported price movement
Quarterly DexCom (DXCM) Trades by Frank Sands
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -4.93 M | Sold Out | 0 | $0.00 |
| Q3 2025 | -5.01 M | Reduce 50.40% | 4.93 M | $67.29 |
| Q2 2025 | -466,212 | Reduce 4.48% | 9.95 M | $87.29 |
| Q1 2025 | -695,345 | Reduce 6.26% | 10.41 M | $68.29 |
| Q4 2024 | +790,303 | Add 7.66% | 11.11 M | $77.77 |
| Q3 2024 | -287,305 | Reduce 2.71% | 10.32 M | $67.04 |
| Q2 2024 | -290,261 | Reduce 2.66% | 10.61 M | $113.38 |
| Q1 2024 | -4.16 M | Reduce 27.64% | 10.9 M | $138.70 |
| Q4 2023 | +1.4 M | Add 10.23% | 15.06 M | $124.09 |
| Q3 2023 | +557,543 | Add 4.26% | 13.66 M | $93.30 |
| Q2 2023 | -635,841 | Reduce 4.63% | 13.1 M | $128.51 |
| Q1 2023 | -1.78 M | Reduce 11.44% | 13.74 M | $116.18 |
| Q4 2022 | -1.18 M | Reduce 7.06% | 15.51 M | $0.11 |
| Q3 2022 | -1.21 M | Reduce 6.75% | 16.69 M | $80.54 |
| Q2 2022 | +1.15 M | Add 6.83% | 17.9 M | $74.53 |
| Q1 2022 | +4.24 M | Add 33.90% | 16.76 M | $127.90 |
| Q4 2021 | -783,112 | Reduce 5.89% | 12.51 M | $134.24 |
| Q3 2021 | +1.15 M | Add 9.45% | 13.3 M | $136.72 |
| Q2 2021 | +403,096 | Add 3.43% | 12.15 M | $106.75 |
| Q1 2021 | +2.58 M | Add 28.18% | 11.75 M | $89.85 |
| Q4 2020 | -162,896 | Reduce 1.75% | 9.16 M | $92.43 |
| Q3 2020 | +1.96 M | Add 26.67% | 9.33 M | $103.06 |
| Q2 2020 | +5.37 M | Add 269.86% | 7.36 M | $101.35 |
| Q1 2020 | +1.99 M | New Buy | 1.99 M | $67.32 |
Frank Sands's DexCom Investment FAQs
Frank Sands first purchased DexCom, Inc. (DXCM) in Q1 2020, acquiring 1,990,680 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Frank Sands has held DexCom, Inc. (DXCM) for 24 quarters since Q1 2020.
Frank Sands's largest addition to DexCom, Inc. (DXCM) was in Q2 2020, adding 7,362,664 shares worth $746.21 M.
According to the latest 13F filing for Q4 2025, Frank Sands's firm, Sands Capital Management, LLC, owns 0 shares of DexCom, Inc. (DXCM), valued at approximately $0.
As of the Q4 2025 filing, DexCom, Inc. (DXCM) represents approximately 0.00% of Frank Sands's publicly disclosed stock portfolio, making it one of their key holdings.
Frank Sands's peak holding in DexCom, Inc. (DXCM) was 17,902,213 shares, as reported at the end of Q2 2022.